^
Association details:
| Biomarker: | NUP98-HOXD11 fusion + Chr t(2;11)(q31;p15) |
|---|---|
| Cancer: | Acute Myelogenous Leukemia |
| Regimen: | (etoposide IV + daunorubicin + cytarabine) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Successful treatment of acute myelomonocytic leukaemia with NUP98–HOXD11 fusion transcripts and monitoring of minimal residual disease
Published date:
01/24/2003
Excerpt:
A 15‐year‐old Japanese boy was referred...Although he achieved complete haematological remission after an 8‐d induction therapy, comprising cytosine arabinoside, daunorubicin and etoposide...an AML‐M4 patient with t(2;11 (q31;p15) and the NUP98–HOXD11 fusion transcripts....He is in continuous complete remission without any significant complications 24...months after his initial diagnosis.
DOI:
https://doi.org/10.1046/j.1365-2141.2003.04052
